First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong; T. Asakura; M. Ishii; S. Yoda; K. Masaki; T. Sakagami; E. Iwasaki; Y. Yamagishi; T. Kanai; T. Betsuyaku; N. Hasegawa

doi:10.1016/j.nmni.2018.10.001

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong
, T. Asakura
, M. Ishii
, S. Yoda
, K. Masaki
, T. Sakagami
, E. Iwasaki
, Y. Yamagishi
, T. Kanai
, T. Betsuyaku
, N. Hasegawa

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

Original language	English
Pages (from-to)	4-6
Number of pages	3
Journal	New Microbes and New Infections
Volume	27
DOIs	https://doi.org/10.1016/j.nmni.2018.10.001
Publication status	Published - 2019 Jan

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anti–interferon gamma (IFN-γ) autoantibody
Mycobacterium aviumcomplex (MAC)
disseminated Mycobacterium aviumcomplex infection
hepatobiliary infection
jaundice

ASJC Scopus subject areas

Microbiology
Infectious Diseases

Access to Document

10.1016/j.nmni.2018.10.001

Cite this

Namkoong, H., Asakura, T., Ishii, M., Yoda, S., Masaki, K., Sakagami, T., Iwasaki, E., Yamagishi, Y., Kanai, T., Betsuyaku, T., & Hasegawa, N. (2019). First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies. New Microbes and New Infections, 27, 4-6. https://doi.org/10.1016/j.nmni.2018.10.001

Namkoong, H, Asakura, T, Ishii, M, Yoda, S, Masaki, K, Sakagami, T, Iwasaki, E, Yamagishi, Y, Kanai, T, Betsuyaku, T & Hasegawa, N 2019, 'First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies', New Microbes and New Infections, vol. 27, pp. 4-6. https://doi.org/10.1016/j.nmni.2018.10.001

@article{81b814b214e4452b98685d6c3c494790,

title = "First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies",

abstract = "This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.",

keywords = "Anti–interferon gamma (IFN-γ) autoantibody, Mycobacterium aviumcomplex (MAC), disseminated Mycobacterium aviumcomplex infection, hepatobiliary infection, jaundice",

author = "H. Namkoong and T. Asakura and M. Ishii and S. Yoda and K. Masaki and T. Sakagami and E. Iwasaki and Y. Yamagishi and T. Kanai and T. Betsuyaku and N. Hasegawa",

note = "Publisher Copyright: {\textcopyright} 2018 The Author(s)",

year = "2019",

month = jan,

doi = "10.1016/j.nmni.2018.10.001",

language = "English",

volume = "27",

pages = "4--6",

journal = "New Microbes and New Infections",

issn = "2052-2975",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

AU - Namkoong, H.

AU - Asakura, T.

AU - Ishii, M.

AU - Yoda, S.

AU - Masaki, K.

AU - Sakagami, T.

AU - Iwasaki, E.

AU - Yamagishi, Y.

AU - Kanai, T.

AU - Betsuyaku, T.

AU - Hasegawa, N.

PY - 2019/1

Y1 - 2019/1

N2 - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

AB - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

KW - Anti–interferon gamma (IFN-γ) autoantibody

KW - Mycobacterium aviumcomplex (MAC)

KW - disseminated Mycobacterium aviumcomplex infection

KW - hepatobiliary infection

KW - jaundice

UR - https://www.scopus.com/pages/publications/85056726089

UR - https://www.scopus.com/pages/publications/85056726089#tab=citedBy

U2 - 10.1016/j.nmni.2018.10.001

DO - 10.1016/j.nmni.2018.10.001

M3 - Article

AN - SCOPUS:85056726089

SN - 2052-2975

VL - 27

SP - 4

EP - 6

JO - New Microbes and New Infections

JF - New Microbes and New Infections

ER -

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this